Donislecel-the first approved pancreatic islet cell therapy medication for type 1 diabetes: a letter to the editor-Reference-Cited by-同舟云学术

Donislecel-the first approved pancreatic islet cell therapy medication for type 1 diabetes: a letter to the editor

Published:2023-07-14 Issue:1 Volume:193 Page:231-232
ISSN:0021-1265
Container-title:Irish Journal of Medical Science (1971 -)
language:en
Short-container-title:Ir J Med Sci

Author:

Affan Muhammad^ORCID,Dar Marrium S.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11845-023-03464-w.pdf

Reference12 articles.

1. DiMeglio LA, Evans-Molina C, Oram RA et al (2018) Type 1 diabetes. The Lancet 391(10138):2449–2462. https://doi.org/10.1016/s0140-6736(18)31320-5

2. Critical ReviewsTM in Immunology (2019) Begell House Digital Library. www.dl.begellhouse.com. https://www.dl.begellhouse.com/journals/2ff21abf44b19838

3. Mobasseri M, Shirmohammadi M, Amiri T et al (2020) Prevalence and Incidence of Type 1 Diabetes in the world: a Systematic Review and meta-analysis. Health Promot Perspect 10(2):98–115. https://doi.org/10.34172/hpp.2020.18

4. Mayer-Davis EJ, Lawrence JM, Dabelea D et al (2017) Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012. N Engl J Med 376(15):1419–1429. https://doi.org/10.1056/nejmoa1610187

5. Hirsch IB, Gaudiani LM (2021) A new look at brittle diabetes. J Diabetes Complicat 35(1):107646. https://doi.org/10.1016/j.jdiacomp.2020.107646

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and challenges of the cell-based therapies among diabetic patients;Journal of Translational Medicine;2024-05-08

2. Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation;Frontiers in Immunology;2024-04-08